Washington, Aug 24 (Prensa Latina) A new therapeutic strategy could avoid chemotherapy in early breast cancer (HER-2+) and thus reduce toxicity associated with its treatment, the American Society of Clinical Oncology said on Wednesday.
Mexico City, Jul 20 (Prensa Latina) Cuba continues to be at the forefront in the development of medical treatments for the benefit of mankind, especially in diseases such as Alzheimer's and Parkinson's disease.
Mexico City, Jul 17 (Prensa Latina) The Mexican newspaper La Jornada on Sunday said that Cuba, pioneer nation in developing new technologies to treat neurodegenerative diseases, is presently applying a too successful treatment against Alzheimer's and Parkinson's.
Washington, Jun 20 (Prensa Latina) A first-randomized controlled trial has shown encouraging results with the use of testosterone replacement therapy in men with sexual function problems, a specialized source reported on Monday.
Havana, Mar 12 (Prensa Latina) Cuba today celebrates World Glaucoma Day with notable breakthroughs for its treatment, while experts recommend an annual ophthalmological check-up to detect the disease in time and avoid irreversible blindness.
Brasilia, jan 4 (Prensa Latina) Doctor Antônio Macedo confirmed today that Brazil's President Jair Bolsonaro, admitted because of an intestinal obstruction, reacts well to medication and ruled out the need for a surgical procedure.
Washington, Oct 14 (Prensa Latina) A team of experts said that Bumetanide -a commonly used and potent oral diuretic pill- may provide an expected yet efficacious treatment for those at genetic risk of Alzheimer's disease, as funded by the National Institute of Aging (NIA).
Geneva, Oct 14 (Prensa Latina) Covid-19 reversed years of global progress in the fight against tuberculosis and, for the first time in more than a decade, the deaths from the latter increased, an official document revealed on Thursday.
Havana, Oct 4 (Prensa Latina) The Center for Genetic Engineering and Biotechnology (CIGB) on Sunday highlighted that new Jusvinza drug is Cuba's first therapeutic product based on synthetic peptide, so its production is expected to ramp up.